1999
DOI: 10.1128/jb.181.5.1576-1584.1999
|View full text |Cite
|
Sign up to set email alerts
|

Direct Selection for Mutators in Escherichia coli

Abstract: We have constructed strains that allow a direct selection for mutators of Escherichia coli on a single plate medium. The plate selection is based on using two different markers whose reversion is enhanced by a given mutator. Plates containing limiting amounts of each respective nutrient allow the growth of ghost colonies or microcolonies that give rise to full-size colonies only if a reversion event occurs. Because two successive mutational events are required, mutator cells are favored to generate full-size c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(12 citation statements)
references
References 64 publications
1
11
0
Order By: Relevance
“…Significant work has been done to study how the balance between adaptive and deleterious mutations in hypermutating strains determines evolutionary outcomes (1, 5-7, 12, 32, 76, 77). Both theoretical and experimental investigations suggest that hypermutators of various strengths will fix by hitchhiking with the adaptive mutations they facilitate under certain conditions (6,14,21,22). This effect has been demonstrated both in vitro and in vivo and is also consistent with the observations of the cooccurrence of hypermutators and drug resistance mutations in chronic infections in humans (23-26, 30, 35-37).…”
Section: Discussionsupporting
confidence: 59%
See 1 more Smart Citation
“…Significant work has been done to study how the balance between adaptive and deleterious mutations in hypermutating strains determines evolutionary outcomes (1, 5-7, 12, 32, 76, 77). Both theoretical and experimental investigations suggest that hypermutators of various strengths will fix by hitchhiking with the adaptive mutations they facilitate under certain conditions (6,14,21,22). This effect has been demonstrated both in vitro and in vivo and is also consistent with the observations of the cooccurrence of hypermutators and drug resistance mutations in chronic infections in humans (23-26, 30, 35-37).…”
Section: Discussionsupporting
confidence: 59%
“…As a result, optimal mutation rates can differ between these high and low extremes and may be dynamically modified by selection, particularly when increases in mutational rate may be beneficial for adapting bacterial populations (6,(14)(15)(16)(17)(18). Supporting this hypothesis, moderately increased mutational rates are shown to be advantageous in both in vitro and in vivo competition experiments under conditions of selective bottlenecks in which sharp reductions in population numbers occur (6,7,(19)(20)(21)(22).…”
mentioning
confidence: 92%
“…Furthermore, bacteria can acquire mutations that increase their genome-wide U typically 10 to 1000-fold -known as "mutators". In fact, it has been long known that recurrent pressure of antibiotics selects for mutator clones due to their increased ability to produce the rare mutations that can rescue bacterial populations from such high selective pressures [20]. Mutators are also known to exhibit increased ability for recombination [21].…”
Section: Emergence Of Bacterial Antibiotic Resistancementioning
confidence: 99%
“…This concept was initially described in Nowell’s paper where he attributes the high number of mutations in cancer genomes to waves of clonal selection [ 5 , 23 ]. Studies in bacteria and yeast imply mutator mutations confer a selective growth advantage on cells harboring these acquired mutations [ 24 , 25 ]. The current mutator hypothesis speculates that a small number of ‘driver’ alterations exist and, once acquired by somatic mutation, confer the cancer phenotype; however, seemingly insignificant ‘passenger’ mutations result via mechanisms yet to be elucidated [ 26 ].…”
Section: Classic View: Heritable Tumor Heterogeneitymentioning
confidence: 99%